PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
20395065-1	2011	PURPOSE: We evaluated dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging (DSC-MRI) using gadoteridol in comparison to the iron oxide nanoparticle blood pool agent, ferumoxytol, in patients with glioblastoma multiforme (GBM) who received standard radiochemotherapy (RCT).	gadoteridol	115-126	desmocollin 3	Homo sapiens	100-103
23730413-6	2013	The contrast enhancement of SBK2-Tris-(Gd-DOTA)3 was significantly higher than that observed with a current MRI macrocyclic gadolinium chelate (Gadoteridol, ProHance) alone or a scrambled control.	gadoteridol	144-155	SH3 domain binding kinase family member 2	Homo sapiens	28-32
23730413-6	2013	The contrast enhancement of SBK2-Tris-(Gd-DOTA)3 was significantly higher than that observed with a current MRI macrocyclic gadolinium chelate (Gadoteridol, ProHance) alone or a scrambled control.	gadoteridol	157-165	SH3 domain binding kinase family member 2	Homo sapiens	28-32
23204544-9	2013	Five patients with mismatched high rCBV with ferumoxytol and low rCBV with gadoteridol had an mOS of 171 days.	gadoteridol	75-86	Moloney sarcoma oncogene	Mus musculus	94-97
21433294-1	2011	Two MRI contrast agents (CAs) composed of Gd-DO3A conjugated to amino acid building blocks derived from glutamic acid (CA1) and lysine (CA2) have been synthesized by using novel alkyne and propionate linkers, and subsequently characterized.	gadoteridol	42-49	carbonic anhydrase 1	Rattus norvegicus	119-122
21433294-1	2011	Two MRI contrast agents (CAs) composed of Gd-DO3A conjugated to amino acid building blocks derived from glutamic acid (CA1) and lysine (CA2) have been synthesized by using novel alkyne and propionate linkers, and subsequently characterized.	gadoteridol	42-49	carbonic anhydrase 2	Rattus norvegicus	136-139
20395065-5	2011	RESULTS: In seven MRI sessions of clinically presumptive active tumor, gadoteridol-DSC showed low rCBV in three and high rCBV in four, whereas ferumoxytol-DSC showed high rCBV in all seven sessions (p = 0.002).	gadoteridol	71-82	desmocollin 3	Homo sapiens	83-86
20551915-2	2010	The magnetic resonance imaging (MRI) contrast agent, Gadoteridol (Gd), was used to monitor CED infusion and to predict the expression pattern of glial cell line-derived neurotrophic factor (GDNF) protein after administration of adeno-associated virus type 2 (AAV2) vector encoding human pre-pro-GDNF complementary DNA.	gadoteridol	53-64	glial cell derived neurotrophic factor	Homo sapiens	190-194
20551915-2	2010	The magnetic resonance imaging (MRI) contrast agent, Gadoteridol (Gd), was used to monitor CED infusion and to predict the expression pattern of glial cell line-derived neurotrophic factor (GDNF) protein after administration of adeno-associated virus type 2 (AAV2) vector encoding human pre-pro-GDNF complementary DNA.	gadoteridol	66-68	glial cell derived neurotrophic factor	Homo sapiens	190-194
17722547-6	2007	The imaging of alpha(v)beta3 integrin with targeted PGA-cystamine-(Gd-DO3A) was evaluated in nude mice bearing DU145 and SLK xenografts at a dose of 5 micromol-Gd/kg.	gadoteridol	67-74	STE20-like kinase	Mus musculus	121-124
18225999-8	2008	Gadoteridol and gadoterate meglumine have a cyclic structure, making them less likely to release free Gd3+, and there is only a single reported case of NSF associated with gadoteridol use alone.	gadoteridol	0-11	GRDX	Homo sapiens	102-105
34802148-9	2022	RESULTS: The contrast-agent concentration in the DP4 phantom was linearly increased over 10 minutes (0.17 mM/min, measurement accuracy: 96%) after injecting gadoteridol (100 mM) at a constant rate (0.24 ml/s, 4 ml).	gadoteridol	157-168	transcription factor Dp family member 3	Homo sapiens	49-52
9626889-5	1998	In vivo, these two solutions of linear Gd chelates significantly inhibited ACE activity (Gd-DTPA: (67 +/- 9% versus baseline; and Gd-DTPA-BMA: 73 +/- 2% versus baseline at the clinical dose of .1 mmol/kg), whereas no significant effect was observed for the two macrocyclic chelates Gd-DOTA and Gd-HP-DO3A.	gadoteridol	294-304	angiotensin I converting enzyme	Homo sapiens	75-78
8208120-3	1994	For Gd-DOTA and Gd-HPDO3A, the mechanism of the interaction with the P-31 nuclei seems to be of the outer sphere type and a better efficiency is noted for the "neutral" Gd-HPDO3A.	gadoteridol	16-25	ATPase H+ transporting V1 subunit E1	Homo sapiens	69-73
8208120-3	1994	For Gd-DOTA and Gd-HPDO3A, the mechanism of the interaction with the P-31 nuclei seems to be of the outer sphere type and a better efficiency is noted for the "neutral" Gd-HPDO3A.	gadoteridol	169-178	ATPase H+ transporting V1 subunit E1	Homo sapiens	69-73
27097822-0	2016	Synergistic Effect of Human Serum Albumin and Fullerene on Gd-DO3A for Tumor-Targeting Imaging.	gadoteridol	59-66	albumin	Mus musculus	34-41
32525582-10	2020	Gadoteridol normalized CA4+ partition correlated significantly (p<0.05) with Mankin score at all time points and with proteoglycan content after 4 hours.	gadoteridol	0-11	carbonic anhydrase 4	Homo sapiens	23-26
32525582-11	2020	The technique is applicable during diffusion, and normalization with gadoteridol partition improves the sensitivity of the CA4+ contrast agent.	gadoteridol	69-80	carbonic anhydrase 4	Homo sapiens	123-126
31850230-3	2019	A targeted macrocyclic gadolinium-based contrast agent (GBCA) ZD2-N3-Gd(HP-DO3A) (MT218), specific to EDB-FN, was developed for MRMI of aggressive breast cancer.	gadoteridol	62-80	fibronectin 1	Homo sapiens	102-105
29654384-7	2018	We employ this technique to improve the sensitivity of cationic CA4+ (q =+4) by normalizing its partition in cartilage with that of non-ionic gadoteridol.	gadoteridol	142-153	carbonic anhydrase 4	Homo sapiens	64-67
31793901-7	2019	As a promiscuous transporter, afamin also seems to bind gadoteridol, a magnetic resonance imaging contrast compound, in at least two sites.	gadoteridol	56-67	afamin	Homo sapiens	30-36
27097822-1	2016	A macromolecular magnetic resonance imaging (MRI) contrast agent was successfully synthesized by conjugating the gadolinium/1,4,7,10-tetraazacyclododecane-1,4,7-tetracetic acid complex (Gd-DO3A) with 6,6-phenyl-C61 butyric acid (PC61BA) and upon further modification with human serum albumin (HSA).	gadoteridol	186-193	macoilin 1	Mus musculus	211-214
27097822-1	2016	A macromolecular magnetic resonance imaging (MRI) contrast agent was successfully synthesized by conjugating the gadolinium/1,4,7,10-tetraazacyclododecane-1,4,7-tetracetic acid complex (Gd-DO3A) with 6,6-phenyl-C61 butyric acid (PC61BA) and upon further modification with human serum albumin (HSA).	gadoteridol	186-193	albumin	Mus musculus	284-291